Gopalakrishnan V - Search Results

1

Chromatin remodelling at the topoisomerase II-beta promoter is associated with enhanced sensitivity to etoposide in human neuroblastoma cell lines.

Das CM, Zage PE, Taylor P, Aguilera D, Wolff JE, Lee D, Gopalakrishnan V. Das CM, et al. Among authors: gopalakrishnan v. Eur J Cancer. 2010 Oct;46(15):2771-80. doi: 10.1016/j.ejca.2010.05.010. Eur J Cancer. 2010. PMID: 20886683 Free PMC article.

2

Predicting tumor cell repopulation after response: mathematical modeling of cancer cell growth.

Zhang M, Das C, Vasquez H, Aguilera D, Zage PE, Gopalakrishnan V, Wolff JE. Zhang M, et al. Among authors: gopalakrishnan v. Anticancer Res. 2006 Jul-Aug;26(4B):2933-6. Anticancer Res. 2006. PMID: 16886616 Free article.

3

Measuring cytotoxicity: a new perspective on LC50.

Zhang M, Aguilera D, Das C, Vasquez H, Zage P, Gopalakrishnan V, Wolff J. Zhang M, et al. Among authors: gopalakrishnan v. Anticancer Res. 2007 Jan-Feb;27(1A):35-8. Anticancer Res. 2007. PMID: 17352213 Free article.

4

Valproic acid induces p21 and topoisomerase-II (alpha/beta) expression and synergistically enhances etoposide cytotoxicity in human glioblastoma cell lines.

Das CM, Aguilera D, Vasquez H, Prasad P, Zhang M, Wolff JE, Gopalakrishnan V. Das CM, et al. Among authors: gopalakrishnan v. J Neurooncol. 2007 Nov;85(2):159-70. doi: 10.1007/s11060-007-9402-7. Epub 2007 May 30. J Neurooncol. 2007. PMID: 17534580

5

Influence of valproic acid on outcome of high-grade gliomas in children.

Masoudi A, Elopre M, Amini E, Nagel ME, Ater JL, Gopalakrishnan V, Wolff JE. Masoudi A, et al. Among authors: gopalakrishnan v. Anticancer Res. 2008 Jul-Aug;28(4C):2437-42. Anticancer Res. 2008. PMID: 18751431 Free article.

6

Histone acetylation resulting in resistance to methotrexate in choroid plexus cells.

Prasad P, Vasquez H, Das CM, Gopalakrishnan V, Wolff JE. Prasad P, et al. Among authors: gopalakrishnan v. J Neurooncol. 2009 Feb;91(3):279-86. doi: 10.1007/s11060-008-9709-z. Epub 2008 Oct 14. J Neurooncol. 2009. PMID: 18853233

7

Reactivation of death receptor 4 (DR4) expression sensitizes medulloblastoma cell lines to TRAIL.

Aguilera DG, Das CM, Sinnappah-Kang ND, Joyce C, Taylor PH, Wen S, Hasselblatt M, Paulus W, Fuller G, Wolff JE, Gopalakrishnan V. Aguilera DG, et al. Among authors: gopalakrishnan v. J Neurooncol. 2009 Jul;93(3):303-18. doi: 10.1007/s11060-008-9788-x. Epub 2009 Jan 16. J Neurooncol. 2009. PMID: 19148581 Free PMC article.

8

The Notch target Hes1 directly modulates Gli1 expression and Hedgehog signaling: a potential mechanism of therapeutic resistance.

Schreck KC, Taylor P, Marchionni L, Gopalakrishnan V, Bar EE, Gaiano N, Eberhart CG. Schreck KC, et al. Among authors: gopalakrishnan v. Clin Cancer Res. 2010 Dec 15;16(24):6060-70. doi: 10.1158/1078-0432.CCR-10-1624. Clin Cancer Res. 2010. PMID: 21169257 Free PMC article.

9

Retinoic acid induces REST degradation and neuronal differentiation by modulating the expression of SCF(β-TRCP) in neuroblastoma cells.

Singh A, Rokes C, Gireud M, Fletcher S, Baumgartner J, Fuller G, Stewart J, Zage P, Gopalakrishnan V. Singh A, et al. Among authors: gopalakrishnan v. Cancer. 2011 Nov 15;117(22):5189-202. doi: 10.1002/cncr.26145. Epub 2011 Apr 26. Cancer. 2011. PMID: 21523764 Free article.

10

The deubiquitylase USP37 links REST to the control of p27 stability and cell proliferation.

Das CM, Taylor P, Gireud M, Singh A, Lee D, Fuller G, Ji L, Fangusaro J, Rajaram V, Goldman S, Eberhart C, Gopalakrishnan V. Das CM, et al. Among authors: gopalakrishnan v. Oncogene. 2013 Mar 28;32(13):1691-701. doi: 10.1038/onc.2012.182. Epub 2012 Jun 4. Oncogene. 2013. PMID: 22665064 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

393 results

Search Page

Filters